Background Prophylaxis of HBV recurrence is critical after liver transplantation in HBV
patients. Despite new prophylactic schemes, most European LT centres persist on a …

There have been great strides in the management of chronic hepatitis B virus (HBV)
infection, but considerable challenges remain. The European Association for the Study of …

The first human orthotopic liver transplantation (LT) in Europe was performed by Sir Roy
Calne in Cambridge in 1968 [1], only one year after the first successful human liver …

Background & Aims All oral direct acting antivirals (DAA) have been shown to improve the
liver function of patients with decompensated cirrhosis but it is presently unknown whether …

Background & Aims Direct-acting antivirals (DAAs) have dramatically improved the outcome
of patients with hepatitis C virus (HCV) infection including those with decompensated …

Abstract Background An estimated 862 000 to 2.4 million people have chronic hepatitis B
infection (CHB). Hepatitis B screening is recommended for pregnant women and …

Long‐term antiviral prophylaxis is required to prevent hepatitis B recurrence for patients with
chronic hepatitis B after liver transplantation. We determined the long‐term outcome of 265 …

Background The objective of the current study was to define the incidence, as well as time
course of mortality within the first year after liver transplantation. Methods Data on adult, first …

Die Medizin unterliegt einem fortwährenden Entwicklungsprozess, sodass alle Angaben,
insbesondere zu diagnostischen und therapeutischen Verfahren, immer nur dem …

These updated guidelines from the Infectious Diseases Community of Practice of the
American Society of Transplantation review the diagnosis, prevention, and management of …